|Positive WB detected in||rat pancreas tissue, mouse pancreas tissue, PC-3 cells, pig pancreas tissue, human adrenal gland tissue|
|Positive IHC detected in||human pancreas tissue, human colon tissue, human lung cancer tissue|
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
|Positive IF detected in||PC-12 cells|
|Western Blot (WB)||WB : 1:1000-1:4000|
|Immunohistochemistry (IHC)||IHC : 1:5000-1:80000|
|Immunofluorescence (IF)||IF : 1:50-1:500|
|Sample-dependent, check data in validation data gallery|
60135-1-Ig targets Chromogranin A in WB, IHC, IF,ELISA applications and shows reactivity with human, rat, pig, mouse samples.
|Tested Reactivity||human, rat, pig, mouse|
|Cited Reactivity||human, mouse|
|Host / Isotype||Mouse / IgG1|
|Immunogen||Chromogranin A fusion protein Ag0807|
|Full Name||chromogranin A (parathyroid secretory protein 1)|
|Calculated molecular weight||51 kDa|
|Observed molecular weight||70 kDa|
|GenBank accession number||BC006459|
|Gene ID (NCBI)||1113|
|Purification Method||Protein A purification|
|Storage Buffer||PBS with 0.02% sodium azide and 50% glycerol pH 7.3.|
|Storage Conditions||Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.|
Chromogranin A is a member of the granin family of neuroendocrine secretory proteins. It is located in secretory vesicles of neurons and endocrine cells. Chromogranin A is the precursor to several functional peptides including vasostatin, pancreastatin, catestatin and parastatin. These peptides negatively modulate the neuroendocrine function of the releasing cell (autocrine) or nearby cells (paracrine). CgA is one of the most used tumor markers in NET's (neuroendocrine tumors) , and elevated CgA concentrations have been demonstrated in serum or plasma of patients with different types of these tumors.
Protocol for Differentiation of Human iPSCs into Pulmonary Neuroendocrine Cells.
N‑Myc induces the tumor progression of prostate cancer by regulating FSCN1.
High throughput proteomic and metabolic profiling identified target correction of metabolic abnormalities as a novel therapeutic approach in head and neck paraganglioma.
Cancer cell's neuroendocrine feature can be acquired through cell-cell fusion during cancer-neural stem cell interaction.
Efficient Generation and Transcriptomic Profiling of Human iPSC-Derived Pulmonary Neuroendocrine Cells.